Hydrogen Recruiting Phase 4 Trials for Percutaneous Coronary Intervention (PCI) / Coronary Artery Disease (CAD) Treatment

IndicationsStatusPurposePhase
RecruitingTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT03378934Anti-platelet Effect of Berberine in Patients After Percutaneous Coronary Intervention